-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LAOBUYcMGc8qldTTZ2mJFShKpYLlNdYXKAId8S5xls4lX7CWgSMhMijaogQNjAPI srTNqr8gS+St6j+/NYDStQ== 0000891020-96-000998.txt : 19960928 0000891020-96-000998.hdr.sgml : 19960928 ACCESSION NUMBER: 0000891020-96-000998 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960821 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: APRIA HEALTHCARE GROUP INC CENTRAL INDEX KEY: 0000882289 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 330488566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-42598 FILM NUMBER: 96618568 BUSINESS ADDRESS: STREET 1: 3560 HYLAND AVE CITY: COSTA MESA STATE: CA ZIP: 92626 BUSINESS PHONE: 7149572000 MAIL ADDRESS: STREET 1: 3560 HYLAND AVENUE CITY: COSTA MESA STATE: CA ZIP: 92626 FORMER COMPANY: FORMER CONFORMED NAME: ABBEY HEALTHCARE GROUP INC/DE DATE OF NAME CHANGE: 19930328 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ARGYROS GEORGE L CENTRAL INDEX KEY: 0001021089 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: ARNEL & AFFILIATES STREET 2: 950 S COAST DR SUITE 200 CITY: COSTA MESA STATE: CA ZIP: 92626 MAIL ADDRESS: STREET 1: ARNEL & AFFILIATES STREET 2: 950 SOUTH COAST DR SUITE 200 CITY: COSTA MESA STATE: CA ZIP: 92626 SC 13D 1 SCHEDULE 13D 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 __________ SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) APRIA HEALTHCARE GROUP INC. - -------------------------------------------------------------------------------- (Name of issuer) COMMON - -------------------------------------------------------------------------------- (Title of class of securities) 037933108 - -------------------------------------------------------------------------------- (CUSIP number) GEORGE L. ARGYROS ARNEL DEVELOPMENT COMPANY 950 SOUTH COAST DRIVE, SUITE 200 COSTA MESA, CA 92626 (714) 434-5050 - -------------------------------------------------------------------------------- (Name, address and telephone number of person authorized to receive notices and communications) JULY 15, 1996 - -------------------------------------------------------------------------------- (Date of event which required filing of this statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1 (b)(3) or (4), check the following box [ ]. Check the following box if a fee is being paid with the statement [X]. (Page 1 of 5 Pages) 2 CUSIP NO. 037933108 13D PAGE 2 OF 5 PAGES - ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS George L. Argyros - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF GROUP* (a) [ ] (b) [ ] - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 3 SEC USE ONLY - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 4 SOURCE OF FUNDS* AF/PF - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ---------- --------------------------------------------------------------------- - --------------------- --------- ------------------------------------------------ 7 SOLE VOTING POWER NUMBER OF 2,753,768 SHARES -0- ------------------------------------------------ BENEFICIALLY 8 SHARED VOTING POWER OWNED BY -0- ------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING 2,753,768 ------------------------------------------------ PERSON WITH 10 SHARED DISPOSITIVE POWER -0- - --------------------- --------- ------------------------------------------------ - ---------- --------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,753,768 - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.42% - ---------- --------------------------------------------------------------------- - ---------- --------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - ---------- --------------------------------------------------------------------- 3 CUSIP NO. 037933108 13D PAGE 3 OF 5 PAGES ITEM 1. SECURITY AND ISSUER. Common Stock APRIA Healthcare Group Inc. 3560 Hyland Avenue Costa Mesa, CA 92626 ITEM 2. IDENTITY AND BACKGROUND. (a) George L. Argyros (b) Arnel Development Company 950 South Coast Drive, Suite 200 Costa Mesa, CA 92626 (c) Chairman and Chief Executive Officer, Arnel Development Company (d) The Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the past five years. (e) During the past five years the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction the result of which subjected the reporting person to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws. (f) The Reporting Person is a U.S. Citizen. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. The Common Stock of APRIA Healthcare Group Inc. (the "Issuer") beneficially owned by the Reporting Person was acquired by the Reporting Person and affiliated entities of the Reporting Person. The Reporting Person and affiliated entities acquired 2,239,618 shares of Common Stock of the Issuer pursuant to the merger of Homedco Group Inc. ("Homedco") into Issuer on June 28, 1995. Pursuant to the merger, shareholders of Homedco received two shares of the Issuer for each share of Homedco. At the time of the merger, the Reporting Person and affiliated entities owned less than 5% of the outstanding shares of Issuer. On March 22, 1996, HBI Financial Corporation, of which the reporting person is the sole shareholder, purchased 500,000 shares of the Issuer in the open market at a purchase price of $29.625. HBI Financial Corporation used its working capital to make this acquisition. The Reporting Person, using personal funds, purchased 10,000 shares of the Issuer on July 15, 1996. Additionally, affiliated entities of the Reporting Person purchased 1,550 shares and 2,600 shares, respectively. Each of the affiliated entities are trusts of which the Reporting Person is a Trustee. Each Trust used its operating income to purchase the Issuer's Common Shares. ITEM 4. PURPOSE OF TRANSACTION. Each of the Reporting Person and affiliated entities made the acquisitions for investment purposes only and not with the intent of acquiring control of the Issuer. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) Account Beneficially Owned: 2,753,768 Percent of Class: 5.42% (b) Number of shares as to which reporting person has: 1. Sole power to vote or direct vote: 2,753,768 4 CUSIP NO. 037933108 13D PAGE 4 OF 5 PAGES 2. Shared power to vote or direct vote: -0- 3. Sole power to dispose or direct the disposition: 2,753,768 4. Shared power to dispose or direct the disposition: -0- (c) The Reporting Person and affiliated entities had the following transactions during the past 60 days: No. of Type of Price Per Entity Shares Transaction Share - ------ ------ ----------- --------- Reporting Person 10,000 Purchase $25.375 The Argyros Children's Trust II 1,550 Purchase $25.25 The Argyros Charitable Trust No. 4 2,600 Purchase $25.25 All of the above purchases were made in the open market. (d) Other Interests: 1. HBI Financial Corporation owns 2,430,670 shares of the Issuer. The Reporting Person is the sole shareholder of HBI Financial Corporation and, therefore, has the power to direct the affairs, including decisions respecting the voting or disposition of shares. 2 GLA Financial Corporation owns 636 shares of the Issuer. The reporting person is the sole shareholder of GLA Financial Corporation and, therefore, has the power to direct the affairs, including decisions respecting the voting or disposition of shares. 3. The Argyros Foundation owns 11,252 shares of the Issuer. The Reporting Person is a Trustee of the Argyros Foundation. 4. Argyros Children's Trust No. II owns 31,050 shares of the Issuer. The Reporting Person is a Trustee of the Argyros Children's Trust No. II. 5. The Argyros Charitable Trust No. 4 owns 2,600 shares of the Issuer. The Reporting Person is a Trustee of The Argyros Charitable Trust No. 4. 6. GLA Foundation, a nonprofit corporation, owns 267,560 shares of the Issuer. The Reporting Person is a director and officer of the GLA Foundation. (e) Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. Not applicable. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Not applicable. 5 CUSIP NO. 037933108 13D PAGE 5 OF 5 PAGES SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. August 20, 1996 --------------------------------------------- (DATE) /s/ George L. Argyros --------------------------------------------- George L. Argyros -----END PRIVACY-ENHANCED MESSAGE-----